Kirkstall Quasi Vivo cell culture system

Wednesday, 14 February, 2018 | Supplied by: Lonza Australia Pty Ltd



A common issue faced by drug discovery scientists who use conventional in vitro culture systems is their poor translatability to humans. To address this problem, Kirkstall’s Quasi Vivo system consists of interconnected cell-culture chambers and a peristaltic pump to create a continuous flow of media over cells. As a result, cultures are exposed to more physiologically relevant conditions, helping researchers improve the predictive value of in vitro experiments.

The system is available with three different culture chambers (QV500, QV600 and QV900) to support a wide range of applications, including submerged cell culture, co-culture and modelling of air-liquid and liquid-liquid interfaces. Not only is the system easy to set up, it also enables close monitoring of variables during an experiment. Furthermore, the large scale and user configurability of the system allow assays to be performed that are not possible using microfluidic systems.

Online: www.lonza.com
Phone: 03 9550 0883
Related Products

BioGX Xfree COVID-19 Direct RT-PCR test

The Xfree COVID-19 Direct RT-PCR test is a complete test in a single vial, lyophilised...

Bio-Rad Laboratories CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems

Bio-Rad Laboratories' CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems are suitable for...

PCR Biosystems NGSBIO Library Quant Kit for Illumina

The kit contains all the components necessary for sensitive quantification of DNA libraries prior...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd